BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38915393)

  • 1. Longitudinal changes in DNA methylation during the onset of islet autoimmunity differentiate between reversion versus progression of islet autoimmunity.
    Carry PM; Vanderlinden LA; Johnson RK; Buckner T; Steck AK; Kechris K; Yang IV; Fingerlin TE; Fiehn O; Rewers M; Norris JM
    Front Immunol; 2024; 15():1345494. PubMed ID: 38915393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Coexpression of Innate Immunity Genes During Persistent Islet Autoimmunity Are Associated With Progression of Islet Autoimmunity: Diabetes Autoimmunity Study in the Young (DAISY).
    Carry PM; Waugh K; Vanderlinden LA; Johnson RK; Buckner T; Rewers M; Steck AK; Yang I; Fingerlin TE; Kechris K; Norris JM
    Diabetes; 2022 Sep; 71(9):2048-2057. PubMed ID: 35724268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study.
    Penno MAS; Oakey H; Augustine P; Taranto M; Barry SC; Colman PG; Craig ME; Davis EA; Giles LC; Harris M; Haynes A; McGorm K; Morahan G; Morbey C; Rawlinson WD; Sinnott RO; Soldatos G; Thomson RL; Vuillermin PJ; Wentworth JM; Harrison LC; Couper JJ
    Pediatr Diabetes; 2020 Sep; 21(6):945-949. PubMed ID: 32430977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY).
    Frederiksen BN; Kroehl M; Fingerlin TE; Wong R; Steck AK; Rewers M; Norris JM
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1845-51. PubMed ID: 23979957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young.
    Frederiksen BN; Steck AK; Kroehl M; Lamb MM; Wong R; Rewers M; Norris JM
    Clin Dev Immunol; 2013; 2013():417657. PubMed ID: 24367383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of slow progression to diabetes in children with multiple islet autoantibodies.
    Steck AK; Dong F; Waugh K; Frohnert BI; Yu L; Norris JM; Rewers MJ
    J Autoimmun; 2016 Aug; 72():113-7. PubMed ID: 27255734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frederiksen B; Liu E; Romanos J; Steck AK; Yin X; Kroehl M; Fingerlin TE; Erlich H; Eisenbarth GS; Rewers M; Norris JM
    J Steroid Biochem Mol Biol; 2013 Jan; 133():51-7. PubMed ID: 22960018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frohnert BI; Ide L; Dong F; Barón AE; Steck AK; Norris JM; Rewers MJ
    Diabetologia; 2017 Jun; 60(6):998-1006. PubMed ID: 28314946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between IgG4 antibodies to dietary factors, islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young.
    Lamb MM; Simpson MD; Seifert J; Scott FW; Rewers M; Norris JM
    PLoS One; 2013; 8(2):e57936. PubMed ID: 23469110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a nested case-control study design for omics investigations in the Environmental Determinants of Islet Autoimmunity cohort.
    Oakey H; Giles LC; Thomson RL; Lê Cao KA; Ashwood P; Brown JD; Knight EJ; Barry SC; Craig ME; Colman PG; Davis EA; Hamilton-Williams EE; Harrison LC; Haynes A; Kim KW; Mallitt KA; McGorm K; Morahan G; Rawlinson WD; Sinnott RO; Soldatos G; Wentworth JM; Couper JJ; Penno MAS;
    Ann Med; 2023 Dec; 55(1):2198255. PubMed ID: 37043275
    [No Abstract]   [Full Text] [Related]  

  • 14. What Have Slow Progressors Taught Us About T1D-Mind the Gap!
    Gillespie KM; Long AE
    Curr Diab Rep; 2019 Sep; 19(10):99. PubMed ID: 31501992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young.
    Elhassan S; Dong F; Buckner T; Johnson RK; Seifert JA; Carry PM; Vanderlinden L; Waugh K; Rewers M; Norris JM
    Front Immunol; 2023; 14():1124370. PubMed ID: 37056761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes.
    Norris JM; Yin X; Lamb MM; Barriga K; Seifert J; Hoffman M; Orton HD; Barón AE; Clare-Salzler M; Chase HP; Szabo NJ; Erlich H; Eisenbarth GS; Rewers M
    JAMA; 2007 Sep; 298(12):1420-8. PubMed ID: 17895458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Stene LC; Barriga K; Hoffman M; Kean J; Klingensmith G; Norris JM; Erlich HA; Eisenbarth GS; Rewers M
    Pediatr Diabetes; 2006 Oct; 7(5):247-53. PubMed ID: 17054445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.